Our results demonstrated that the shRNA clones (D11 and 1005) strongly inhibited CCR5 expression in primary PBMC at days 7 and 12 post-infection (Fig. 4, C) while H3 shRNA demonstrated some inhibition. The gene discussed is CCR5; the disease is infection.